Chemotherapeutic strategies for renal cell carcinoma

被引：27

作者：

Milowsky, MI ^{[1
]}

Nanus, DM ^{[1
]}

机构：

[1] Cornell Univ, Weill Med Coll, Dept Med, Div Hematol Med Oncol, New York, NY 10021 USA

来源：

UROLOGIC CLINICS OF NORTH AMERICA | 2003年 / 30卷 / 03期

关键词：

D O I：

10.1016/S0094-0143(03)00031-4

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Metastatic renal cell carcinoma (RCC) is a disease that is highly resistant to systemic chemotherapy Responses to combination chemotherapy have been reported in patients with collecting duct carcinoma and the sarcomatoid variant of renal cancer. Clinical trials combining chemotherapy with biologic response modifiers have not resulted in significant advances in the treatment of RCC. Patients with advanced local or metastatic RCC should be offered investigational therapeutic options. The identification of novel agents with significantly improved antitumor activity remains a high priority in the treatment of this disease.

引用

页码：601 / +

页数：10

共 50 条

[31] The chemotherapeutic effects of rapamycin in a human metastatic renal carcinoma cell line, MSKRCC54.
Sadhukhan, P
DiDonato, J
Liou, LS
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1209S - 1209S
[32] Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells
Yuan, Zhi-xiang
Mo, Jingxin
Zhao, Guixian
Shu, Gang
Fu, Hua-lin
Zhao, Wei
FRONTIERS IN PHARMACOLOGY, 2016, 7
[33] High dose chemotherapeutic strategies in the treatment of epithelial ovarian carcinoma
McAfee, SL
Seiden, MV
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1999, 11 (01) : 17 - 21
[34] Renal cell carcinoma with caval involvement: Contemporary strategies of surgical treatment
Manassero, Francesca
Mogorovich, Andrea
Di Paola, Giuseppe
Valent, Francesca
Perrone, Vittorio
Signori, Stefano
Boggi, Ugo
Selli, Cesare
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (06) : 745 - 750
[35] Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma
Lindner, Andrea Katharina
Tulchiner, Gennadi
Seeber, Andreas
Siska, Peter J.
Thurnher, Martin
Pichler, Renate
FRONTIERS IN ONCOLOGY, 2022, 12
[36] THE THERAPY OF THE ADVANCED RENAL CELL CARCINOMA - NEW AGENTS AND STRATEGIES Abstracts
不详
JOURNAL OF IMAB, 2010, 16 (01): : 3 - 58
[37] Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now?
Bedke, Jens
Stenzl, Arnulf
EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (12) : 1399 - 1408
[38] Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?
Da Costa, Ines Anselmo
Rausch, Steffen
Kruck, Stephan
Todenhoefer, Tilman
Stenzl, Arnulf
Bedke, Jens
EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (04) : 357 - 368
[39] Dosing strategies and optimization of targeted therapy in advanced renal cell carcinoma
Ryan, Christopher W.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (01) : 43 - 55
[40] Therapiestrategien des fortgeschrittenen NierenkarzinomsTherapy strategies for advanced renal cell carcinoma
M. Staehler
N. Haseke
G. Schöppler
T. Stadler
C. Adam
C. G. Stief
Der Urologe, 2006, 45 (1): : 99 - 112

← 1 2 3 4 5 →